Nutraceuticals in Patients With Heart Failure: A Systematic Review

[1]  Akshay S. Desai,et al.  Nutrition, Obesity, and Cachexia in Patients With Heart Failure: A Consensus Statement from the Heart Failure Society of America Scientific Statements Committee. , 2019, Journal of cardiac failure.

[2]  F. Galletti,et al.  Nutrients and Nutraceuticals for the Management of High Normal Blood Pressure: An Evidence-Based Consensus Document , 2019, High Blood Pressure & Cardiovascular Prevention.

[3]  P. Ponikowski,et al.  Iron Deficiency in Heart Failure: An Overview. , 2019, JACC. Heart failure.

[4]  P. Macdonald,et al.  National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Australian clinical guidelines for the management of heart failure 2018 , 2018, The Medical journal of Australia.

[5]  E. Manzato,et al.  Nutraceuticals and functional foods for the control of plasma cholesterol levels. An intersociety position paper , 2018, Pharmacological research.

[6]  D. Panagiotakos,et al.  The Role of Nutraceuticals in Statin Intolerant Patients. , 2018, Journal of the American College of Cardiology.

[7]  S. Russell,et al.  Trends in Hospitalizations and Survival of Acute Decompensated Heart Failure in Four US Communities (2005–2014): ARIC Study Community Surveillance , 2018, Circulation.

[8]  A. Coggan,et al.  Dietary Nitrate Increases VO2peak and Performance but Does Not Alter Ventilation or Efficiency in Patients With Heart Failure With Reduced Ejection Fraction. , 2017, Journal of cardiac failure.

[9]  J. Gummert,et al.  Effect of vitamin D on all-cause mortality in heart failure (EVITA): a 3-year randomized clinical trial with 4000 IU vitamin D daily , 2017, European heart journal.

[10]  Yan Liu,et al.  Efficacy of coenzyme Q10 in patients with cardiac failure: a meta-analysis of clinical trials , 2017, BMC Cardiovascular Disorders.

[11]  Zongguo Yang,et al.  Efficacy and Safety of L-Carnitine Treatment for Chronic Heart Failure: A Meta-Analysis of Randomized Controlled Trials , 2017, BioMed research international.

[12]  A. Cicero,et al.  Nutraceuticals and Dietary Supplements to Improve Quality of Life and Outcomes in Heart Failure Patients. , 2017, Current pharmaceutical design.

[13]  J. Mccans,et al.  Dietary nitrate supplementation and exercise tolerance in patients with heart failure with reduced ejection fraction. , 2017, American journal of physiology. Regulatory, integrative and comparative physiology.

[14]  M. Anguita-Sánchez,et al.  Nutritional Intervention in Malnourished Hospitalized Patients with Heart Failure. , 2016, Archives of medical research.

[15]  P. Ponikowski,et al.  Effects of intravenous iron therapy in iron‐deficient patients with systolic heart failure: a meta‐analysis of randomized controlled trials , 2016, European journal of heart failure.

[16]  P. James,et al.  Dietary nitrate increases exercise tolerance in patients with non-ischemic, dilated cardiomyopathy-a double-blind, randomized, placebo-controlled, crossover trial. , 2016, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[17]  S. Plein,et al.  Effects of Vitamin D on Cardiac Function in Patients With Chronic HF , 2016, Journal of the American College of Cardiology.

[18]  Wei-Long Jiang,et al.  Vitamin D Supplementation in the Treatment of Chronic Heart Failure: A Meta‐analysis of Randomized Controlled Trials , 2016, Clinical cardiology.

[19]  A. Coggan,et al.  Acute Dietary Nitrate Intake Improves Muscle Contractile Function in Patients With Heart Failure: A Double-Blind, Placebo-Controlled, Randomized Trial , 2015, Circulation. Heart failure.

[20]  E. Okello,et al.  Effect of Coenzyme Q10 on the Incidence of Atrial Fibrillation in Patients With Heart Failure , 2015, Journal of Investigative Medicine.

[21]  R. Townsend,et al.  Effect of Inorganic Nitrate on Exercise Capacity in Heart Failure With Preserved Ejection Fraction , 2015, Circulation.

[22]  M. Metra,et al.  Effects of oral administration of orodispersible levo-carnosine on quality of life and exercise performance in patients with chronic heart failure. , 2015, Nutrition.

[23]  F. Rosenfeldt,et al.  The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial. , 2014, JACC. Heart failure.

[24]  Yasser Shahrour,et al.  Coenzyme Q10 for heart failure. , 2014, The Cochrane database of systematic reviews.

[25]  C. Neville,et al.  The effect of multiple micronutrient supplementation on left ventricular ejection fraction in patients with chronic stable heart failure: a randomized, placebo-controlled trial. , 2014, JACC. Heart failure.

[26]  B. Hoit,et al.  The effect of vitamin d on aldosterone and health status in patients with heart failure. , 2014, Journal of cardiac failure.

[27]  M. Anguita-Sánchez,et al.  Justificación y diseño del estudio PICNIC: Programa de IntervenCión Nutricional en pacientes hospitalizados por Insuficiencia Cardiaca desnutridos , 2014 .

[28]  J. Suárez de Lezo,et al.  Rationale and design of PICNIC study: nutritional intervention program in hospitalized patients with heart failure who are malnourished. , 2014, Revista espanola de cardiologia.

[29]  Antonello Santini and Ettore Novellino.  Nutraceuticals: Beyond the Diet Before the Drugs , 2014 .

[30]  Amit Sood,et al.  Use of complementary therapies in cardiovascular disease. , 2013, The American journal of cardiology.

[31]  L. Bazzano,et al.  Effect of coenzyme Q₁₀ supplementation on heart failure: a meta-analysis. , 2013, The American journal of clinical nutrition.

[32]  I. Piña,et al.  A randomized controlled trial of high dose vitamin D3 in patients with heart failure. , 2013, JACC. Heart failure.

[33]  Xiaoying Li,et al.  Effects of fish oil supplementation on cardiac function in chronic heart failure: a meta-analysis of randomised controlled trials , 2012, Heart.

[34]  C. Hoppel,et al.  Improved Mitochondrial Function with Diet-Induced Increase in Either Docosahexaenoic Acid or Arachidonic Acid in Membrane Phospholipids , 2012, PloS one.

[35]  L. Tavazzi,et al.  Effects of n-3 polyunsaturated fatty acids on malignant ventricular arrhythmias in patients with chronic heart failure and implantable cardioverter-defibrillators: A substudy of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca (GISSI-HF) trial. , 2011, American heart journal.

[36]  L. Tavazzi,et al.  Effects of n‐3 polyunsaturated fatty acids and of rosuvastatin on left ventricular function in chronic heart failure: a substudy of GISSI‐HF trial , 2010, European journal of heart failure.

[37]  F. Dini,et al.  Effects of L-arginine on the Minnesota Living with Heart Failure Questionnaire quality-of-life score in patients with chronic systolic heart failure. , 2009, Medical science monitor : international medical journal of experimental and clinical research.

[38]  B. Gillespie,et al.  Hawthorn Extract Randomized Blinded Chronic Heart Failure (HERB CHF) Trial , 2009, European journal of heart failure.

[39]  L. Tavazzi,et al.  Effect of n-3 polyunsaturated fatty acids and rosuvastatin in patients with heart failure: results of the GISSI-HF trial , 2009, Expert review of cardiovascular therapy.

[40]  O. Stepura,et al.  Magnesium orotate in severe congestive heart failure (MACH). , 2009, International journal of cardiology.

[41]  M. Gheorghiade,et al.  The Role of n-3 PUFAs in Preventing the Arrhythmic Risk in Patients with Idiopathic Dilated Cardiomyopathy , 2009, Cardiovascular Drugs and Therapy.

[42]  Wilhelm Gaus,et al.  The efficacy and safety of Crataegus extract WS® 1442 in patients with heart failure: The SPICE trial , 2008, European journal of heart failure.

[43]  C. Frampton,et al.  Coenzyme Q10: an independent predictor of mortality in chronic heart failure. , 2008, Journal of the American College of Cardiology.

[44]  Gissi-Hf Investigators.  Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial , 2008, The Lancet.

[45]  Mark T. Gladwin,et al.  The nitrate–nitrite–nitric oxide pathway in physiology and therapeutics , 2008, Nature Reviews Drug Discovery.

[46]  E. Ernst,et al.  Hawthorn extract for treating chronic heart failure. , 2008, The Cochrane database of systematic reviews.

[47]  K. Adarsh,et al.  Coenzyme Q10 (CoQ10) in isolated diastolic heart failure in hypertrophic cardiomyopathy (HCM) , 2008, BioFactors.

[48]  G. Tenderich,et al.  Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. , 2006, The American journal of clinical nutrition.

[49]  E. Ernst,et al.  Adverse-Event Profile of Crataegus Spp. , 2006, Drug safety.

[50]  M. Condorelli,et al.  Effect of coenzyme Q10 therapy in patients with congestive heart failure: a long-term multicenter randomized study , 2004, The clinical investigator.

[51]  J. Cox,et al.  Use of complementary and alternative medical therapies in patients with cardiovascular disease. , 2003, American heart journal.

[52]  Shu Q. Liu,et al.  1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system , 2002 .

[53]  Z. Zuo,et al.  Hawthorn , 2002, Journal of clinical pharmacology.

[54]  A. Langer,et al.  A controlled clinical trial of vitamin E supplementation in patients with congestive heart failure. , 2001, The American journal of clinical nutrition.

[55]  M. Fisher,et al.  The Effect of Coenzyme Q10 in Patients with Congestive Heart Failure , 2000, Annals of Internal Medicine.

[56]  F. Rosenfeldt,et al.  Cardioprotection by orotic acid: metabolism and mechanism of action. , 1997, Journal of molecular and cellular cardiology.

[57]  D. Loew.  Phytotherapy in heart failure. , 1997, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[58]  M. Motro,et al.  Improved left ventricular function after thiamine supplementation in patients with congestive heart failure receiving long-term furosemide therapy. , 1995, The American journal of medicine.

[59]  K. Swedberg,et al.  Coenzyme Q10 as an adjunctive in the treatment of chronic congestive heart failure. The Q10 Study Group. , 1995, Journal of cardiac failure.

[60]  C. Glueck,et al.  The important role of modifiable dietary and behavioral characteristics in the causation and prevention of coronary heart disease hospitalization and mortality: the prospective NHANES I follow-up study. , 1995, Journal of the American College of Nutrition.

[61]  M. Ploch,et al.  Efficacy of the Hawthorn (Crataegus) preparation LI 132 in 78 patients with chronic congestive heart failure defined as NYHA functional class II. , 1994, Phytomedicine : international journal of phytotherapy and phytopharmacology.